Sigma Pharmaceuticals Limited
(ASX:SIP) has reported that its revenue shot up 28% to $2.15 billion in the first half of this year. The company says this was heavily influenced by the PBS listing of high cost, low margin Hepatitis C medications from March 2016.
Sigma owns the well-known pharmacy brands, Amcal and Guardian. More recently, it added Discount Drug Stores, Pharmasave and Chemist King to its brand portfolio, and claims to have the largest pharmacy footprint in Australia. In addition, the company has expanded into China by opening an online Amcal store in the Chinese-language (cn.amcal.com.au).
Sigma also reported that its underlying NPAT rose 14.5% to $31.7 million.
The company will pay its shareholders a dividend of 2.5 cents per share, which will be paid on 3 October.
